logo
Select company
Select metric
-427.77%EBIT Margin
VS
Market
7
Sector
26
Industry
46
History
71
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -301.19M-427.77%$ 70.41M
3/31/2025$ -354.4M-747.61%$ 47.4M
12/31/2024$ -400.67M-971.48%$ 41.24M
9/30/2024$ -337.59M-317.29%$ 106.4M
6/30/2024$ -445.67M-458.3%$ 97.24M
3/31/2024$ -503.14M-552.52%$ 91.06M
12/31/2023$ -541.49M-626.32%$ 86.45M
9/30/2023$ -655.93M-5779.62%$ 11.35M
6/30/2023$ -591.62M-5704.03%$ 10.37M
3/31/2023$ -557.56M-5932.09%$ 9.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -7706.84%.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average EBIT % has been -3346%.
  • The median EBIT % for SAGE THERAPEUTICS INC during this period was -859.54%
  • SAGE THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 59.8%.
  • The lowest EBIT % recorded by SAGE THERAPEUTICS INC in the same timeframe -8162.17%

SAGE THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
KURA : KURA ONCOLOGY INC -232.16%TBPH : THERAVANCE BIOPHARMA INC 55.25%NKTR : NEKTAR THERAPEUTICS -128.27%ZVRA : ZEVRA THERAPEUTICS INC 48.18%LXRX : LEXICON PHARMACEUTICALS INC -184.91%ADCT : ADC THERAPEUTICS SA -153.4%YMAB : Y-MABS THERAPEUTICS INC -31.21%GOSS : GOSSAMER BIO INC -326.37%EYPT : EYEPOINT PHARMACEUTICALS INC -337.55%AUTL : AUTOLUS THERAPEUTICS PLC -803.46%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for SAGE THERAPEUTICS INC is calculated as follows: EBIT [ $ -537.48M ] / Revenues [ $ 6.97M ]
(=) EBIT % [ -7706.84% ]

SAGE - EBIT Margin, Last 5 years

-8162.17%

Minimum

Jun 30, 2022

59.8%

Maximum

Jun 30, 2021

-3346%

Average

-859.54%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%